Biovica International AB (publ) (STO:BIOVIC.B)
0.5280
+0.0380 (7.76%)
Jul 24, 2026, 5:29 PM CET
Biovica International AB Revenue
In the fiscal year ending April 30, 2026, Biovica International AB had annual revenue of 15.10M SEK with 37.76% growth. Biovica International AB had revenue of 5.22M in the quarter ending April 30, 2026, with 59.83% growth.
Revenue
15.10M
Revenue Growth
+37.76%
P/S Ratio
11.43
Revenue / Employee
539.40K
Employees
25
Market Cap
154.13M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 15.10M | 4.14M | 37.76% |
| Apr 30, 2025 | 10.96M | 2.66M | 32.00% |
| Apr 30, 2024 | 8.30M | 2.61M | 45.79% |
| Apr 30, 2023 | 5.70M | -601.00K | -9.55% |
| Apr 30, 2022 | 6.30M | -2.58M | -29.08% |
| Apr 30, 2021 | 8.88M | -1.04M | -10.51% |
| Apr 30, 2020 | 9.92M | -523.00K | -5.01% |
| Apr 30, 2019 | 10.44M | 499.00K | 5.02% |
| Apr 30, 2018 | 9.95M | 4.37M | 78.45% |
| Apr 30, 2017 | 5.57M | -3.08M | -35.60% |
| Apr 30, 2016 | 8.65M | 3.64M | 72.73% |
| Apr 30, 2015 | 5.01M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 31.83M |
| Alzinova AB | 25.66M |
| Elicera Therapeutics AB | 10.64M |
| NextCell Pharma AB | 9.24M |
| Xintela AB | 2.59M |
| Simris Group AB (PUBL) | 1.88M |
| Alligator Bioscience AB | 520.00K |
| Diamyd Medical AB | 432.00K |
Biovica International AB News
- 5 weeks ago - Biovica International AB Quarterly report: Q4 2026 - Filings
- 5 weeks ago - Biovica International AB Annual report: Q4 2026 - Filings
- 4 months ago - Biovica International AB Transcript: Q3 25/26 - Transcripts
- 4 months ago - Biovica International AB Quarterly report: Q3 2026 - Filings
- 4 months ago - Biovica International AB Slides: Q3 2026 - Filings
- 7 months ago - Biovica International AB Transcript: Q2 25/26 - Transcripts
- 7 months ago - Biovica International AB Quarterly report: Q2 2026 - Filings
- 7 months ago - Biovica International AB Slides: Q2 2026 - Filings